The frissonnant mutant mouse, a model of dopamino-sensitive, inherited motor syndrome

Neurobiology of Disease

Volumn 8, Issue 3, 2001, Pages 447-458

  Callizot, N ^a,b   Guenet J L ^c   Baillet, C ^b   Warter, J M ^a   Poindron, P ^a  

^a UNIVERSITÉ DE STRASBOURG   (France)

^b Neurofit SAS   (France)

^c INSTITUT PASTEUR   (France)

Author keywords

[No Author keywords available]

Indexed keywords

APOMORPHINE; LEVODOPA; ROPINIROLE; SELEGILINE; TYROSINE 3 MONOOXYGENASE;

AMNESIA; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; AUTOSOMAL RECESSIVE DISORDER; CONTROLLED STUDY; DOPAMINERGIC SYSTEM; GENE MUTATION; LOCOMOTION; MOUSE; NIGRONEOSTRIATAL SYSTEM; NONHUMAN; PARKINSON DISEASE; PRIORITY JOURNAL; STEREOTYPY; TREMOR;

EID: 0034988226     PISSN: 09699961     EISSN: None     Source Type: Journal    
DOI: 10.1006/nbdi.2001.0393     Document Type: Article

References (24)

1. A primate model of parkinsonism: Selective destruction of dopaminergic neurons in pars compacta of the subtantia nigra by 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridoxine
2. Genetics of Parkinson's disease
3. N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) disreupts social memory/recognition processes in the male mouse
4. Ageing and Parkinson's disease: Substantia nigra regional selectivity
5. MPTP-induced behavioral and biochemical deficits: A parametric analysis
6. MPTP-induced hypoactivity in mice: Reversal by L-Dopa
7. Correlation between the neostriatal content of the 1-methyl-4-phenylpyridinium species and dopaminergic neurotoxicity following 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine administration to several strains of mice
8. Aged mice are more sensitive to 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine treatment than young adults
9. The etiology of depression in Parkinson's disease patients
10. Neurotoxicity of the meperidine analogue N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine on brain catecholamine neurons in the mouse
11. Dopaminergic neurotoxicity of N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine in mice
12. Attempts to combine 2-deoxyglucose autoradiography and tyrosine hydroxylase immunohistochemistry
13. Accuracy of clinical diagnosis of idiopathic Parkinson's disease: A clinico-pathological study of 100 cases
14. Emerging perspectives in Parkinson's disease
15. Epidemiological survey of dementia in parkinsonism and control population
16. Aging and 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced degeneration of dopaminergic neurons in the substantia nigra
17. The overall rod performance test in the MPTP-treated-mouse model of Parkinsonism
18. Temporal ordering and short-term memory deficits in Parkinson's disease
19. Chronic neurochemical and behavioral changes in MPTP-lesioed C57BL/6 mice: A model for Parkinson's disease
20. Postsynaptic supersensitivity after 6-hydroxydopamine induced degeneration of the nigro-striatal dopamine system
21. Histochimical, biochemical and behavioral consequences of MPTP treatment in C-57 black mice